|
 |
|
|
|
|
154. R.G. Stevens et al., "Body Iron Stores and the Risk of Cancer," New England Journal of Medicine 319 (16): 1047-52 (1988). |
|
|
|
 |
|
|
|
|
155. L.J. Lu et al., "Effects of Soya Consumption for One Month on Steroid Hormones in Premenopausal Women: Implications for Breast Cancer Risk Reduction," Cancer Epidemiology, Biomarkers and Prevention 5 (1): 63-70 (1996). |
|
|
|
 |
|
|
|
|
156. A. Moltini et al., "In Vitro Hormonal Effects of Soybean Isoflavones," Journal of Nutrition 125 (3 Suppl): 751-756S (1995). |
|
|
|
 |
|
|
|
|
157. E. Kyle et al., "Genistein-induced Apoptosis of Prostate Cancer Cells Is Preceded by a Specific Decrease in Focal Adhesion Kinase Activity," Molecular Pharmacology 51 (2): 193-200 (1997). |
|
|
|
 |
|
|
|
|
158. D.M. Walker, "Bovine and Shark Cartilage," Townsend Newsletter (June 1989). |
|
|
|
 |
|
|
|
|
159. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 163. |
|
|
|
 |
|
|
|
|
160. "Shark Cartilage Flunks Cancer Test," Townsend Letter for Doctors and Patients (1987), 26. |
|
|
|
 |
|
|
|
|
161. J.E Dorgan et al., "Relationship of Serum DHEA, DHEA Sulfate and 5-Androstene 3-Beta, 17-Betadiol to Risk of Breast Cancer in Postmenopausal Women," Cancer Epidemiology, Biomarkers and Prevention 6: 177-81 (1997). |
|
|
|
 |
|
|
|
|
162. M.H. Davidson et al., "Safety and Endocrine Effects of 3-Acetyl-7-oxo-DHEA (7-Keto DHEA)," Chicago Center for Clinical Research, Chicago, Ill. 60610. Accepted for Presentation at Experimental Biology 98, April 19, 1998, San Francisco, Calif. |
|
|
|
 |
|
|
|
|
163. R. Sahelian, Pregnenolone: Nature's Feel Good Hormone (Garden City Park, N.Y.: Avery Publishing Group, Inc., 1997). |
|
|
|
 |
|
|
|
|
164. L. Tamarkin et al., "Decreased Nocturnal Plasma Melatonin Peak in Patients with Estrogen Receptor Positive Breast Cancer," Science 216 (4549): 1003-5 (1982). |
|
|
|
 |
|
|
|
|
165. P. Lissoni et al., "A Randomized Study of Neuroimmunotherapy with Low-dose Subcutaneous Interleukin-2 Plus Melatonin Compared to Supportive Care Alone in Patients with Untreatable Metastatic Solid Tumor," Supportive Gain in Cancer 3 (3): 194-97 (1995). |
|
|
|
 |
|
|
|
|
166. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 75. |
|
|
|
 |
|
|
|
|
167. P. Montilla et al., "Hyperlipidemic Nephropathy Induced by Adriamycin: Effect of Melatonin Administration," Nephron 76 (3): 345-50 (1997). |
|
|
|
|
|